SCHEMBL78555

SCHEMBL78555

Cc1ccccc1/C=C/C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.62
CA2 P00918 1/20 0.62
NFKB1 P19838 1/20 0.62
CA4 P22748 1/20 0.62
PTGER3 P43115 7/20 0.55
PTGER2 P43116 7/20 0.55
PTGER4 P35408 6/20 0.55
PTGER1 P34995 3/20 0.55
HDAC3 O15379 1/20 0.54
TNKS O95271 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC1 Q13547 1/20 0.54
HCAR2 Q8TDS4 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
TNKS2 Q9H2K2 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78556 1.00 CA1 (0.62) CA1CA2NFKB1CA4PTGER3
SCHEMBL2425317 1.00 CA1 (0.62) CA1CA2NFKB1CA4PTGER3
SCHEMBL29386378 1.00 CA1 (0.62) CA1CA2NFKB1CA4PTGER3
Hydrochloric Acid SCHEMBL9445634 0.98 CA1 (0.60) CA1CA2NFKB1CA4PTGER3
Ammonia Solution, Strong SCHEMBL6324720 0.98 CA1 (0.60) CA1CA2NFKB1CA4PTGER3
Hydrochloric Acid SCHEMBL16239458 0.98 CA1 (0.60) CA1CA2NFKB1CA4PTGER3
Ammonia Solution, Strong SCHEMBL6324726 0.98 CA1 (0.60) CA1CA2NFKB1CA4PTGER3
SCHEMBL5666241 0.98 CA1 (0.60) CA1CA2NFKB1CA4PTGER3
SCHEMBL5666236 0.98 CA1 (0.60) CA1CA2NFKB1CA4PTGER3
Tert-Butylamine SCHEMBL1879651 0.91 CA1 (0.53) CA1CA2NFKB1CA4PTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4302747-B1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT OREAL (FR) 2026-01-14 EP claimed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
EP-4213764-B1 INTRAOCULAR LENS ZEISS CARL MEDITEC AG (DE) 2025-12-10 EP claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
EP-4444108-B1 ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT SYMRISE AG (DE) 2025-09-10 EP claimed
CN-115959962-B Visible light-promoted halogenated alkane hydrodehalogenation method 中国科学院兰州化学物理研究所 2025-05-23 CN claimed
WO-2025081932-A1 RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF 深圳市护家科技有限公司 2025-04-24 WO claimed
EP-4525822-A1 ANTIMICROBIAL MIXTURES Symrise AG (DE) 2025-03-26 EP claimed
WO-2025026525-A1 HETEROCYCLIC COMPOUNDS AS PHYSIOLOGICAL COOLANTS SYMRISE AG (DE) 2025-02-06 WO claimed
EP-4469439-A1 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2024-12-04 EP claimed
US-5763128-A Simulated photographic-quality images on a substrate without curl XEROX CORPORATION (US) 1998-06-09 US claimed
EP-0619321-A1 Very large scale immobilized peptide synthesis AFFYMAX TECHNOLOGIES N.V. (AN) 1994-10-12 EP claimed
US-5223631-A Epooxidation of olefinically unsaturated substrate NATIONAL SCIENCE COUNCIL (TW) 1993-06-29 US claimed
EP-0342804-B1 TRIOXANE COMPOSITION AND INSECT-PROOFING AGENT MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1992-12-02 EP claimed
EP-0341707-B1 PHENYLETHANOL ESTER OF ORTHO-CINNAMIC ACID, ITS PREPARATION AND USE AS FRAGRANCE COMPOUND Consortium für elektrochemische Industrie GmbH (DE) 1992-09-02 EP claimed
EP-0476014-A1 VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS. AFFYMAX TECH NV (NL) 1992-03-25 EP claimed
EP-0247946-B1 PROCESS FOR NEUTRALIZING UNPLEASANT ODOURS OF ANIMAL EXCRETA ROBERTET S.A. (FR) 1991-12-11 EP claimed
WO-1990015070-A1 VERY LARGE SCALE IMMOBILIZED PEPTIDE SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (AN) 1990-12-13 WO claimed
EP-0166542-A2 Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 EP claimed
EP-0154530-A2 Medicinal substance Robinson, Reuben Judah (ZA) 1985-09-11 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 CA1 4319/4885CA2 3362/4885NFKB1 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.